In The Conversation, Dr. Melissa Armstrong discusses Lewy body dementia, the second most common degenerative dementia.
UF was the No. 2 enroller of patients for multisite ALS trial.
New study led by Dr. Melissa Armstrong and Andrea Kurasz published in the Journal of Alzheimer’s Disease.
New, more diverse image better represents who is affected by Parkinson disease, and how.
New preclinical research shows a commonly used Type 2 diabetes drug can improve symptoms in a specific genetic form of ALS and frontotemporal dementia in mice.
In a Nature Medicine news feature, Dr. Michael Okun discusses the challenges that follow some neural implant trials.
New York Times article exploring possible link between some cases of Parkinson’s and exposure to toxic chemicals cites expertise of Dr. Michael Okun.
Dr. Valerie Joers will lead study seeking to identify novel approaches to treat Parkinson’s disease.
Dr. Michael Okun discusses why it's important for patients with Parkinson's disease to alert their hospital caretakers.
New grant will enable 1 Florida ADRC to continue its work with a bolstered focus on advancing understanding of dementias in diverse populations.